Current Trainees
Biomedical Engineering
Damea Pham
Elevating the efficacy of Clinical Islet Transplantation (CIT) by improving beta cell viability and function through surface conjugation of poly(ethylene) glycol (PEG) to the pancreatic islet capsule
immunology & Microbiology
Miguel Medina-Serpas
Characterizing the follicular helper T-cell (Tfh) response in the secondary lymphatic tissue of human donors across the natural progression of T1D
Immunology & Microbiology
Teng-Hong (Alex) Hung
Exploring the mechanisms of anti-PD-1-induced-T1D in various mouse models to elucidate how different genetic predispositions contribute to T1D onset during checkpoint inhibitor therapy
Clinical and Health Psychology
Hannah Manis
Developing a prototype of an innovative exposure and response prevention treatment for fear of hypoglycemia that is based in virtual reality environments
Former Trainees
Trainee | Name and Degree | Research | Mentors | Position | Employer |
|---|---|---|---|---|---|
 | Joshua Stewart, PhD | A dual-sized microparticle system for inducing immune tolerance in autoimmunity | Benjamin Keselowsky, PhD | Consultant | Charles River Associates |
 | Melanie Shapiro, PhD | Insulin-like growth factors as biomarkers with immunological impacts on the development of T1D | Mark Atkinson, PhD and Todd Brusko, PhD | Postdoc Assoc | University of Florida |
 | Andrea Lin, PhD | Immune changes with ATG+GCSF therapy and Its impacts on C-peptide preservation in T1D | Clayton Mathews, PhD, Michael Haller, MD, and Benjamin Keselowsky, PhD | Medical Science Liaison | EMD Serono, Inc. |
 | Nicholas Abuid, PhD | Engineering cerium oxide nanoparticle coatings for antioxidant/anti-inflammatory protection of biomaterials and tissue grafts | Cherie Stabler, PhD | Postdoc Assoc | University of Florida |
 | Lucas Armitage, PhD | PTPN22 regulates induced MHC-II expression in macrophages | Mark Wallet, PhD and Clayton Mathews, PhD | Postdoc Assoc | University of Colorado, Denver |
 | Elliott Dirr, PhD | Treatment of cardiometabolic dysfunction using targeted parasympathetic neuromodulation | Kevin Otto, PhD | Postdoc Assoc | University of Toledo |
 | Matthew Becker, PhD | Advancing Therapies that Target the PD-1/PD-L1 Pathway for Type 1 Diabetes Autoimmunity | Edward Phelps, PhD | Postdoc Assoc | Arizona State University |
 | Leeana Peters, PhD | Identification of Adaptive Immune Signatures and Dysregulated Pathways in Type 1 Diabetes | Todd Brusko, PhD and Cherie Stabler, PhD | Postdoc Assoc | University of Florida |
 | Alexander Kwiatkowski, PhD | A tolerogenic dual microparticle system for treatment of multiple sclerosis | Benjamin Keselowsky, PhD | Postdoc Assoc | Vanderbilt University |
 | Mollie Huber, BS | Investigating type 1 diabetes pathogenesis with the live pancreas tissue slice platform | Mark Atkinson, PhD and Clayton Mathews, PhD | Pre-doctoral Fellow (NIH F31) | University of Florida |
 | Magdalena Samojlik, BS | Engineering a dynamic three-dimensional in vitro platform for the investigation of human Type 1 Diabetes immunopathogenesis | Cherie Stabler, PhD and Clayton Mathews, PhD | Pre-doctoral Fellow (NIH F31) | University of Florida |
 | Christopher Ludtka, BS | Angiogenic and inflammatory responses of endothelial cells and immune cells such as macrophages to unique environments and stimuli including utilizing simulated microgravity as a potentially pro-angiogenic culture environment, drug responses for cardiovascular applications, as well as sex-based differences studies | Josephine Allen, PhD | Graduate Assistant | University of Florida |